NCT00525265View on ClinicalTrials.gov

A Clinical Pharmacological Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Cardiac Edema
Interventions
DRUG

OPC-41061(Tolvaptan)

Subjects will be orally administered OPC-41061 7.5 mg or 15 mg once daily after breakfast for seven days.

DRUG

Placebo

Subjects will be orally administered placebo once daily after breakfast for seven days.

Trial Locations (2)

Unknown

Kanto Region

Kyushu Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY